retatrutide clinical trials dosage Reta trial data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 for metabolic health — targeting GLP-1, GIP Retatrutide for Weight Loss: 2026

Standard Titration Schedule Dosing facts Injection frequency: Once weekly, on the same day each week Administration: Subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm Half-life: Approximately 6 days, meaning it takes about 45 weeks to reach steady-state levels at each dose Storage: Lyophilized (freeze-dried) powder must be reconstituted with bacteriostatic water and stored at 28C (refrigerated) Not everyone needs 12mg: Many users find 8mg sufficient for their weight loss goals The 4-week intervals between dose increases aren't arbitrary

The price we quote is what you pay

Drinking alcohol increased appetite score in the control group, but not in the GLP-1RA group (Group x Time interaction ( 2 (1) = 5.9106, p = 0.015, f = 0.57

With a US presence spanning 40 years, Novo Nordisk US is headquartered in New Jersey and employs over 10,000 people throughout the country across 12 manufacturing, R&D and corporate locations in eight states plus Washington DC

2 mL luer lock syringe For doses over 1 mL

Half-life and steady state considerations Retatrutide has a half-life of approximately 6 days